InsidersTradesSigma
Follow the CellaVision AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, CellaVision AB has published 0 insider filings. Market capitalisation: €3.4bn. All data is accessible without an account.
Analysts rate CellaVision AB Strong Buy (bullish), based on 4 analysts. Average price target: SEK 176.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
CellaVision AB is a company specializing in the development of image analysis solutions for medical diagnostics. It primarily focuses on automating the analysis of blood cells.